Clinical trial NCT06551714: The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery
Official title: The Effect of Neurophysiological Facilitation Techniques on Pulmonary Function, Respiratory Muscle Strength and Functional Capacity in The Early Stage After Open Heart Surgery
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Open Heart Surgery
Cardiovascular Disease
Physiotherapy
Keywords: Neurophysiological facilitation technique
Cardiac rehabilitation
Lead sponsor: Dogus Universitesi
Sponsor class: OTHER
First posted: 2024-08-13
Enrollment: 32
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation?

Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation?

Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Detailed description: In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

The study was performed on 32 patients who underwent open heart surgery. Patients divided into two groups which study group (n=18) and control group (n=14).

Range of motion, breathing and mobilization exercises within the scope of phase 1 cardiac rehabilitation program were applied to the control group; in addition to the phase 1 cardiac rehabilitation program, neurophysiological facilitation techniques (perioral stimulation, intercostal tension, anterior basal lift, vertebral pressure, moderate manual pressure and abdominal co-contraction) were applied to the study group.

Sociodemographic features and disease-specific findings were recorded on the first postoperative day .

Vital signs, functional capacity, pulmonary function, fatigue and dyspnea of every patient were recorded before and after each treatment on the first four postoperative days.

Functional capacity was evaluated using Timed Up and Go (TUG) test and 2-Minutes Walking test (2MWT). Pulmonary function was examined using a peak flow meter and respiratory muscle strength was measured using an intraoral pressure measurement device. In addition, fatigue and dyspnea perception was measured using Modified Borg Scale.

Before the first day treatment and after the last day treatment of the four-day treatment, patients' fatigue severity were assessed with using Fatigue Severity Scale (FSS), anxiety and depression level with using Hospital Anxiety Depression Scale (HADS), fear of movement with using TAMPA Kinesiophobia Scale and life quality with using the Minnesota Heart Failure Questionnaire.

Before each treatment chest circumference measurements were taken, and the perceived pain severity was recorded using Visual Analog Scale (VAS).

Eligibility criteria: Inclusion Criteria:

* Having open heart surgery for the first time,
* Being between the ages of 18-75,
* Being fully cooperative

Exclusion Criteria:

* Having facial, sternum and rib fractures,
* Having chronic renal failure,
* Development of cerebrovascular accident,
* Having cognitive dysfunction,
* Development of deep vein thrombosis in the post-operative period,
* Having neuromuscular disease,
* Having an orthopedic disability,
* Intubation time longer than 24 hours,
* Staying in intensive care for more than 48 hours

Primary outcomes:
measure: İnspiratory muscle strength
timeFrame: Before and after treatment on each day of treatment, up to 3 month
measure: Expiratory muscle strength
timeFrame: After and before treatment on each day of treatment, up to 3 month
measure: 2 Minute Walk Test
timeFrame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month
measure: Time Up and Go (TUG)
timeFrame: first day of treatment before treatment and last day of treatment after treatment, up to 3 month
measure: Vital sign
timeFrame: Before and after treatment on each day of treatment, up to 3 month
measure: Respiratory frequency
timeFrame: Before and after treatment on each day, up to 3 month
measure: Blood pressure
timeFrame: Before and after treatment on day of treatment, up to 3 month
measure: Heart rate
timeFrame: Before and after treatment on each day of treatment, up to 3 month
measure: Life quality
timeFrame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month
measure: Depression
timeFrame: Before treatment on the first day of treatment and after treatment on last day of treatment, up to 3 month
measure: Symptom
timeFrame: Before and after treatment on each day of treatment, up to 3 month
Secondary outcomes:
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Lokman Hekim Akay Hospital
Study officials:
affiliation: Istinye University
name: Yasemin Cirak, Prof. Dr.
role: PRINCIPAL_INVESTIGATOR
affiliation: Istinye University
name: Feyza merakli
role: STUDY_DIRECTOR
References: